F2RL1 and atopic eczema: Furthermore, clinical studies have demonstrated increased serine protease activity and elevated PAR2 expression in lesional skin relative to non-lesional skin in patients with atopic dermatitis, providing translational evidence supporting a pathogenic role for PAR2 [16,19].